abstract |
FIELD: chemistry. n SUBSTANCE: invention relates to a compound of formula or a pharmaceutically acceptable salt thereof. The invention also relates to a pharmaceutical composition for treating β-amyloid diseases and synucleinopathies, based on said compound. n EFFECT: obtaining a novel compound and a pharmaceutical composition based thereon, which can be used in medicine to treat such diseases as Alzheimer's disease and Parkinson's disease. n 17 cl, 38 dwg, 14 ex |